0001209191-19-020686.txt : 20190320
0001209191-19-020686.hdr.sgml : 20190320
20190320200017
ACCESSION NUMBER: 0001209191-19-020686
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190319
FILED AS OF DATE: 20190320
DATE AS OF CHANGE: 20190320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahatme Sandesh
CENTRAL INDEX KEY: 0001511034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 19695751
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-19
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001511034
Mahatme Sandesh
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
EVP, CFO & CBO
Common Stock
2019-03-19
4
M
0
11768
23.85
A
15636
D
Common Stock
2019-03-19
4
M
0
3511
13.90
A
19147
D
Common Stock
2019-03-19
4
M
0
164
13.71
A
19311
D
Common Stock
2019-03-19
4
M
0
43
13.71
A
19354
D
Common Stock
2019-03-19
4
F
0
2625
126.47
D
16729
D
Common Stock
12012
I
By trust
Stock option (right to buy)
23.85
2019-03-19
4
M
0
11768
0.00
D
2013-11-05
2022-11-05
Common Stock
11768
0
D
Stock option (right to buy)
13.90
2019-03-19
4
M
0
3511
0.00
D
2016-02-27
2025-02-27
Common Stock
3511
2625
D
Stock option (right to buy)
13.71
2019-03-19
4
M
0
164
0.00
D
2017-02-28
2026-02-28
Common Stock
164
3370
D
Stock option (right to buy)
13.71
2019-03-19
4
M
0
43
0.00
D
2017-02-28
2026-02-28
Common Stock
43
478
D
Represents shares of common stock owned by the reporting person that were delivered to the Company to pay the aggregate exercise price with respect to the option exercises reported on this Form 4 filing. Such an "option swap" enables the exercise and holding of shares of Common Stock by the reporting person.
/s/ David Tyronne Howton, as Attorney-in-Fact for Sandesh Mahatme
2019-03-20